养血清脑颗粒治疗偏头痛临床观察

Clinical Observation on Yangxue Qingnao Granule in the Treatment of Migraine

目的研讨养血清脑颗粒治疗偏头痛的成效。方法选择2019年11月—2020年11月沈阳医学院附属第二医院收治的100例偏头痛患者入组进行研究,随机分为试验组、参照组,每组50例患者;试验组应用养血清脑颗粒治疗,参照组应用盐酸氟桂利嗪胶囊治疗;对比2组患者偏头痛改善情况、VAS评分、疼痛持续时间等指标。结果试验组的临床治疗总有效率是94.00%(47/50),明显高于参照组的76.00%(38/50),组间差异具有统计学意义(P<0.05)。试验组治疗之前的VAS评分和头痛持续时间与参照组相比差异无统计学意义,P>0.05;治疗之后,试验组的VAS评分低于参照组,头痛持续时间短于参照组,组间差异具有统计学意义(P<0.05)。结论偏头痛患者使用养血清脑颗粒进行治疗的效果更好,可有效缓解患者临床症状、减少发作次数、缩短疾病的发作时间,值得临床大力推广运用。

Objective To investigate the therapeutic effect of Yangxue Qingnao granules in the treatment of migraine.Methods A total of 100 migraine patients admitted to the Second Affiliated Hospital of Shenyang Medical College from November 2019 to November 2020 were selected and randomly divided into experimental group and reference group,with 50 patients in each group.The experimental group was treated with Yangxue Qingnao granules and the control group was treated with flunarizine hydrochloride capsules.The improvement of migraine,VAS score,pain duration and other indicators were compared between the two groups.Results The total effective rate of the experimental group was 94.00%(47/50),which was significantly higher than that of the control group(76.00%,38/50),and the difference between groups was statistically significant(P<0.05).VAS score and headache duration of experimental group before treatment were not statistically significant compared with the reference group(P>0.05)After treatment,VAS score of experimental group was lower than that of reference group,headache duration was shorter than that of reference group,and the difference between groups was statistically significant(P<0.05).Conclusion Yangxue Qingnao granules in the treatment of migraine has better effect,can effectively alleviate the clinical symptoms of patients,reduce the number of attacks,shorten the onset of the disease time,and is worthy of clinical promotion and application.